GlassScriptPhysician profile
Sana M Idrees
NPI 1407233547
$808.98
in general payments reported to CMS, 2019-2025
14 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $79.45 · 2021: $83.25 · 2022: $108 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $141.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $169.90 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $123.06 | 2025 | Caplyta |
| Sanofi-Aventis U.S. LLC | $101.02 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.85 | 2019-2020 | |
| Novo Nordisk INC | $78.34 | 2019-2020 | |
| Amgen INC. | $66.63 | 2019-2021 | |
| Pfizer INC. | $62.36 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $23.12 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.51 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $21.74 | 2022 | |
| Sandoz INC. | $18.64 | 2025 | Cimerli |
| Merck Sharp & Dohme LLC | $15.35 | 2019 | |
| Lilly USA, LLC | $14.15 | 2021 | |
| Allergan, INC. | $13.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sana Idrees listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.